Avalo Therapeutics Inc (AVTX) earnings · rev $59.0K
These earnings events as JSON? API free 100/dayAvalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
This AVTX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AVTX revenue for 2025-12-31 was $59.0K. Net income was -$78.3M. Revenue was down 86.6% from 2024-12-31 to 2025-12-31. AVTX currently screens at market cap $51.5M.
When the next AVTX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 86.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full AVTX research stays on the stock page; the tape stays on the quote page.
AVTX earnings FAQ
What are AVTX's latest revenue and net income?
Latest cached Avalo Therapeutics Inc (AVTX) revenue for Dec 31, 2025 was $59.0K. Net income was -$78.3M. Statements: https://lician.com/financials/avtx
What is AVTX's latest diluted EPS?
Latest cached Avalo Therapeutics Inc (AVTX) diluted EPS for Dec 31, 2025 was -$5.84.
What period does the latest AVTX earnings print cover?
The latest cached Avalo Therapeutics Inc (AVTX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did AVTX revenue change from the prior cached period?
Cached Avalo Therapeutics Inc (AVTX) revenue was down 86.6% from $441.0K (Dec 31, 2024) to $59.0K (Dec 31, 2025). Statements: https://lician.com/financials/avtx
Where are AVTX earnings listed?
Cached earnings facts for Avalo Therapeutics Inc (AVTX) are listed at https://lician.com/earnings/avtx. Statements: https://lician.com/financials/avtx
Not investment advice.